BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

2025-Jan

12345678

 

BOFAS Hosted Events

BOFAS Principles Course - Dubai

The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery.

There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab.

This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area.

Venue - Le Meridien, Dubai, United Arab Emirates

Documents to download

BOFAS Principles Course Taunton

These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023.

Venue - Taunton (TBC)

 

 

Documents to download


 

BOFAS Affiliated Courses

Other External Events / Courses

Togay Koç
/ Categories: Abstracts, 2023, Poster

Outcomes following extracorporeal shockwave therapy for the treatment of insertional and non-insertional Achilles tendinopathy at 2 year follow-up: a retrospective review

J. Butler, D. Zheng, B. DeClouette, C. Walls, G. Jejelava, M. Azam, J. Kennedy

Introduction: The purpose of this retrospective clinical study was to evaluate outcomes following extracorporeal shockwave therapy (ESWT) for the treatment of Achilles tendinopathy.

Methods: This retrospective cohort study included clinical data from 95 patients who underwent ESWT for insertional (IAT) or non-insertional (NAT) Achilles tendinopathy between 3/3/2017 to 2/8/2022 with a minimum of 1 year follow-up. Data regarding patient demographics, subjective clinical outcomes, radiographic outcomes, treatment characteristics, complications and failures were recorded. Failure was defined as no improvement in VISA-A nor VAS scores and/ or surgical intervention. Subgroup analysis was conducted to identify predictors of poor outcomes. Paired student’s t-tests and Welch’s t-tests were calculated. Regression analysis was carried out to identify predictors of poor outcomes.

Results: In total, 95 patients (109 ankles) with a mean age of 54.1 ± 14.0 years underwent ESWT for Achilles tendinopathy at a mean follow-up of 25.7 ± 15.0 months. Thirty-nine patients were in the NAT cohort and 56 patients were in the IAT cohort. Both NAT and IAT cohorts had a similar improvement in VISA-A score (p=0.365), VAS scores (p=0.65) and demonstrated a similar return to play time (p=0.34). There was a higher failure rate in the IAT cohort (51.8%) than the NAT cohort (23.1%). Patients who received platelet-rich plasma (PRP) had a higher failure rate (71.4%) than those who did not receive PRP (19.6%). Regression models found that treatment with PRP, MRI severity and female sex were associated with worse outcomes.

Conclusion: This retrospective study demonstrated a high failure rate at short-term follow-up in patients who underwent ESWT for insertional Achilles tendinopathy. Predictors of poor outcomes included treatment with PRP, MRI severity and female sex. Further studies with larger patient cohorts and longer follow-up are necessary to determine the role of ESWT in the treatment of Achilles tendinopathy.

Print
362